Printer Friendly
The Free Library
19,585,946 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Accounting Problems at Serologicals Corporation Leads to Shareholder Suits, Announces Berman DeValerio & Pease.


Business Editors and Legal Writers

BOSTON--(BUSINESS WIRE)--May 30, 2000

Berman, DeValerio & Pease pease  
n. pl. pease or peas·en Archaic
A pea.



[Middle English; see pea.
 LLP LLP - Lower Layer Protocol  

a law firm specializing in representing

shareholders in class action lawsuits class action lawsuit

A lawsuit in which one party or a limited number of parties sue on behalf of a larger group to which the parties belong. For example, investors may bring a class action lawsuit against a brokerage firm that has actively promoted a tax
,

issues the following press release:

A shareholder class action was filed against Serologicals Corporation ("SERO SERO Southeast Regional Office
SERO Sekundaerrohstoffe (recycling, former GDR)
SERO Syringe Exchange Resources Online
SERO System Engineering/Engineer Release Order
SERO Site Emergency Response Organisation (nuclear) 
" or the "Company") (NasdaqNM:SERO) in the United States District Court United States District Court

In the U.S., any of the 94 trial courts of general jurisdiction in the federal judicial system. Each state, as well as the District of Columbia and the Commonwealth of Puerto Rico, has at least one federal district court.
 for the District of Northern District of Georgia Georgia, country, Asia
Georgia (jôr`jə), Georgian Sakartvelo, Rus. Gruziya, officially Republic of Georgia, republic (2005 est. pop. 4,677,000), c.26,900 sq mi (69,700 sq km), in W Transcaucasia.
. The action seeks damages for violations of the federal securities laws on behalf of all investors who purchased Serologicals common stock between April 27, 1999 and April 10, 2000 (the `Class Period").

The lawsuit lawsuit: see procedure; tort.  charges Serologicals and certain of its directors and officers, with violations of the federal securities laws by issuing a series of false and misleading financial statements and press releases concerning the Company's publicly reported revenues and earnings. On April 10, 2000, Serological serological

pertaining to or emanating from serology.


serological test
one involving examination of blood serum usually for antibody.
 shocked the investment community by announcing that it was restating its previously recorded revenues for the first three quarter of 1999, including a reversal of approximately $1.4 million in revenue. As a result of these false and misleading statements, the Company's stock traded at artificially inflated prices during the Class Period.

If you purchased Serologicals common stock during the Class Period and suffered a loss on your investment, you may wish to contact the lawyers at Berman, DeValerio & Pease LLP to discuss your rights and interests:

Patrick T. Egan, Esq.

Jeffrey C. Block, Esq.

Berman, DeValerio & Pease LLP

One Liberty Square

Boston, MA 02109

E-Mail: bdplaw@bermanesq.com.

(800) 516-9926

To learn more about this action, other cases or class actions in general, you can also visit our website at www.bermanesq.com.

If you wish to apply to be Lead Plaintiff in this action, a motion must be filed on your behalf with the court no later than June 20, 2000. To be a member of the class you need not take any action at this time. To serve as lead plaintiff, however, you must meet certain legal requirements and you may retain counsel of your own choice. You may contact the attorneys at Berman, DeValerio & Pease LLP to discuss your rights regarding the appointment of lead plaintiff and your interest in the class action.

With offices in Boston and San Francisco San Francisco (săn frănsĭs`kō), city (1990 pop. 723,959), coextensive with San Francisco co., W Calif., on the tip of a peninsula between the Pacific Ocean and San Francisco Bay, which are connected by the strait known as the Golden , Berman, DeValerio & Pease LLP has extensive experience prosecuting shareholder class actions. The firm has been appointed lead counsel in numerous actions involving companies that have issued false and misleading statements, has successfully litigated these actions, and has been singled out for its excellence by many courts. The firm prides itself on its responsiveness to shareholders and their needs in particular cases.
COPYRIGHT 2000 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 30, 2000
Words:431
Previous Article:Flashcom and Texas Instruments Join Forces to Simplify Nationwide Delivery of DSL Services.
Next Article:Executives of the New Daisytek to Host Office Products Leaders; Memphis Conference to Introduce Wholesale Distributor's Low-cost Model to $100...
Topics:



Related Articles
Notice to Investors of Bristol-Myers Squibb; MicroStrategy; Serologicals; Stone & Webster and Pacific Gateway Exchange Regarding Shareholder Lawsuits...
Serologicals Corporation Restates Financial Statements and is Sued by Shareholder, Announces Berman DeValerio & Pease.
Berman, Devalerio & Pease LLP Announces Filing of Shareholder Suits Against Bristol-Myers Squibb --BMY--;.
Berman, DeValerio & Pease LLP Announces Class Periods for the Following Cases:.
Serologicals Corporation Accounting Woes Leads to Shareholder Suits, Announces Berman DeValerio & Pease.
Berman, DeValerio & Pease Announces Lawsuits Against Bristol-Myers Squibb; Serologicals, Inc.; SCB Computer Technology, Inc.; Stone & Webster, Inc....
Berman, DeValerio & Pease Announces Lawsuits Against Bristol-Myers Squibb; Serologicals, Inc.; SCB Computer Technology, Inc.; Stone & Webster, Inc....
Berman DeValerio & Pease Announces Class Periods for the Following Cases:.
Thomas & Betts Corporation Shareholders Pursue Class Action, Says Berman DeValerio & Pease.
CAMARILLO FIRM HIT WITH 8TH SUIT.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles